{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Apoptosis", "Leukemia", "PARP1", "SGP-17-S", "target spot"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38602586", "DateCompleted": {"Year": "2024", "Month": "04", "Day": "12"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "30"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1007/s12032-024-02324-6"], "ArticleDate": [{"Year": "2024", "Month": "04", "Day": "11"}], "Journal": {"ISSN": "1559-131X", "JournalIssue": {"Volume": "41", "Issue": "5", "PubDate": {"Year": "2024", "Month": "Apr", "Day": "11"}}, "Title": "Medical oncology (Northwood, London, England)", "ISOAbbreviation": "Med Oncol"}, "ArticleTitle": "A novel \u03b1,\u03b2-unsaturated ketone inhibits leukemia cell growth as PARP1 inhibitor.", "Pagination": {"StartPage": "113", "MedlinePgn": "113"}, "Abstract": {"AbstractText": ["Leukemia is a malignant disease of the hematopoietic system, in which clonal leukemia cells accumulate and inhibit normal hematopoiesis in the bone marrow and other hematopoietic tissues as a result of uncontrolled proliferation and impaired apoptosis, among other mechanisms. In this study, the anti-leukemic effect of a compound (SGP-17-S) extracted from Chloranthus multistachys, a plant with anti-inflammatory, antibacterial and anti-tumor effects, was evaluated. The effect of SGP-17-S on the viability of leukemic cell was demonstrated by MTT assay, cell cycle, and apoptosis were assessed by flow cytometry using PI staining and Annexin V/PI double staining. Combinations of network pharmacology and cellular thermal shift assay (CETSA) with western blot were used to validate agents that act on leukemia targets. The results showed that SGP-17-S inhibited the growth of leukemia cells in a time- and dose-dependent manner. SGP-17-S blocked HEL cells in the G2 phase, induced apoptosis, decreased Bcl-2 and caspase-8 protein expression, and increased Bax and caspase-3 expression. In addition, CETSA revealed that PARP1 is an important target gene for the inhibition of HEL cell growth, and SGP-17-S exerted its action on leukemia cells by targeting PARP1. Therefore, this study might provide new solutions and ideas for the treatment of leukemia."], "CopyrightInformation": "\u00a9 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Human Brain Bank for Functions and Diseases of Department of Education of Guizhou Province, College of Basic Medical, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}], "LastName": "Zhao", "ForeName": "Weijia", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Human Brain Bank for Functions and Diseases of Department of Education of Guizhou Province, College of Basic Medical, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}], "LastName": "Mo", "ForeName": "Min", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China."}], "LastName": "Yu", "ForeName": "Jia", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China."}], "LastName": "Cheng", "ForeName": "Sha", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GuiZhou KingMed Center for Clinical Laboratory Co., Ltd, Guiyang, 550014, China."}], "LastName": "Long", "ForeName": "Guiping", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Human Brain Bank for Functions and Diseases of Department of Education of Guizhou Province, College of Basic Medical, Guizhou Medical University, Guiyang, 550025, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}], "LastName": "Luo", "ForeName": "Zhiqiong", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, An Shun City People's Hospital, Anshun, 561000, China."}], "LastName": "Liang", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, An Shun City People's Hospital, Anshun, 561000, China. nazi3647@sina.com."}], "LastName": "Yan", "ForeName": "Chen", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Human Brain Bank for Functions and Diseases of Department of Education of Guizhou Province, College of Basic Medical, Guizhou Medical University, Guiyang, 550025, China. luoheng71050@aliyun.com."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China. luoheng71050@aliyun.com."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China. luoheng71050@aliyun.com."}], "LastName": "Luo", "ForeName": "Heng", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Human Brain Bank for Functions and Diseases of Department of Education of Guizhou Province, College of Basic Medical, Guizhou Medical University, Guiyang, 550025, China. sunbaofei@sina.com."}], "LastName": "Sun", "ForeName": "Baofei", "Initials": "B"}], "GrantList": [{"GrantID": "QKHZC[2021]YB450", "Agency": "the Department of Science and Technology of Guizhou Province", "Country": ""}, {"GrantID": "QKHZC[2022]YB189", "Agency": "the Department of Science and Technology of Guizhou Province", "Country": ""}, {"GrantID": "QKHPTRC-GCC[2022]034-1", "Agency": "the Guizhou Provincial Committee Organization Department", "Country": ""}, {"GrantID": "ASKS(2021)19", "Agency": "the Science and Social Development of Anshun City", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Med Oncol", "NlmUniqueID": "9435512", "ISSNLinking": "1357-0560"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Annexin A5"}, {"RegistryNumber": "EC 2.4.2.30", "NameOfSubstance": "PARP1 protein, human"}, {"RegistryNumber": "EC 2.4.2.30", "NameOfSubstance": "Poly (ADP-Ribose) Polymerase-1"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leukemia"}, {"QualifierName": [], "DescriptorName": "Cell Cycle"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Cell Division"}, {"QualifierName": [], "DescriptorName": "Annexin A5"}, {"QualifierName": [], "DescriptorName": "Poly (ADP-Ribose) Polymerase-1"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Pelcovits A, Niroula R. Acute myeloid leukemia: a review. R I Med J. 2020;103(3):38\u201340."}, {"Citation": "Omer FAA, Hashim NM, Ibrahim MY, et al. Beta-mangostin demonstrates apoptogenesis in murine leukaemia (WEHI-3) cells in vitro and in vivo. BMC Complement Altern Med. 2017;17(1):366.", "ArticleIdList": ["28716025", "5513316", "10.1186/s12906-017-1867-0"]}, {"Citation": "Norouzi S, Norouzi M, Amini M, et al. Two COX-2 inhibitors induce apoptosis in human erythroleukemia K562cells by modulating NF-\u03baB and FHC pathways. Daru. 2016;24:1.", "ArticleIdList": ["26739353", "4704250", "10.1186/s40199-015-0139-0"]}, {"Citation": "Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.", "ArticleIdList": ["36633525", "10.3322/caac.21763"]}, {"Citation": "Cao H, Xu Y, de Necochea-Campion R, et al. Application of vitamin D and vitamin D analogs in acute myelogenous leukemia. Exp Hematol. 2017;50:1\u201312.", "ArticleIdList": ["28174131", "10.1016/j.exphem.2017.01.007"]}, {"Citation": "DiNardo CD, Cortes JE. New treatment for acute myelogenous leukemia. Expert Opin Pharmacother. 2015;16(1):95\u2013106.", "ArticleIdList": ["25480777", "10.1517/14656566.2015.981527"]}, {"Citation": "Floren M, Gillette JM. Acute myeloid leukemia: therapy resistance and a potential role for tetraspanin membrane scaffolds. Int J Biochem Cell Biol. 2021;137: 106029.", "ArticleIdList": ["34174403", "8292225", "10.1016/j.biocel.2021.106029"]}, {"Citation": "Devine SM, Larson RA. Acute leukemia in adults: recent developments in diagnosis and treatment. CA Cancer J Clin. 1994;44(6):326\u201352.", "ArticleIdList": ["7953914", "10.3322/canjclin.44.6.326"]}, {"Citation": "Seth R, Singh A. Leukemias in Children. Indian J Pediatr. 2015;82(9):817\u201324.", "ArticleIdList": ["25680783", "10.1007/s12098-015-1695-5"]}, {"Citation": "Major CK, Kantarjian H, Sasaki K, et al. Survivorship in AML: a landmark analysis on the outcomes of acute myelogenous leukemia patients after maintaining complete remission for at least 3 years. Leuk Lymphoma. 2020;61(13):3120\u20137.", "ArticleIdList": ["32755333", "10.1080/10428194.2020.1802450"]}, {"Citation": "Kayser S, Levis MJ. Updates on targeted therapies for acute myeloid leukaemia. Br J Haematol. 2022;196(2):316\u201328.", "ArticleIdList": ["34350585", "10.1111/bjh.17746"]}, {"Citation": "Stubbins RJ, Francis A, Kuchenbauer F, et al. Management of Acute myeloid leukemia: a review for general practitioners in oncology. Curr Oncol. 2022;29(9):6245\u201359.", "ArticleIdList": ["36135060", "9498246", "10.3390/curroncol29090491"]}, {"Citation": "Grimwade D, Ivey A, Huntly BJ. Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. Blood. 2016;127(1):29\u201341.", "ArticleIdList": ["26660431", "4705608", "10.1182/blood-2015-07-604496"]}, {"Citation": "Rose-Inman H, Kuehl D. Acute leukemia. Hematol Oncol Clin North Am. 2017;31(6):1011\u201328.", "ArticleIdList": ["29078921", "10.1016/j.hoc.2017.08.006"]}, {"Citation": "Ding HM, Chen XJ, Chen HM, et al. Effect of Sargassum fusiforme polysaccharide on apoptosis and its possible mechanism in human erythroleukemia cells. Chin J Nat Med. 2020;18(10):749\u201359.", "ArticleIdList": ["33039054"]}, {"Citation": "Ganesan S, Mathews V, Vyas N. Microenvironment and drug resistance in acute myeloid leukemia: do we know enough? Int J Cancer. 2022;150(9):1401\u201311.", "ArticleIdList": ["34921734", "10.1002/ijc.33908"]}, {"Citation": "Huang X, Xiao F, Li Y, et al. Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia. J Exp Clin Cancer Res. 2018;37(1):310.", "ArticleIdList": ["30541583", "6291981", "10.1186/s13046-018-0976-z"]}, {"Citation": "Weiming Huang FC, Bian Yuting, Zhang Ruizeng, et al. Chemical constituents from Chloranthus multistachys and their anti-inflammatory activity. Nat Product Res Dev. 2020;32(10):1688\u201397."}, {"Citation": "Yang X. Bioactive material basis of medicinal plants in genus Chloranthus. Mod Chin Med. 2017;19(04):459\u201395."}, {"Citation": "Xu JB, Yu J, Zhang WQ, et al. Constituents from Chloranthus multistachys and their cytotoxic activities against various human cancer cell lines. J Asian Nat Prod Res. 2023;25(4):330\u201341.", "ArticleIdList": ["35788164", "10.1080/10286020.2022.2092474"]}, {"Citation": "Rose M, Burgess JT, O\u2019Byrne K, et al. PARP inhibitors: clinical relevance, mechanisms of action and tumor resistance. Front Cell Dev Biol. 2020;8: 564601.", "ArticleIdList": ["33015058", "7509090", "10.3389/fcell.2020.564601"]}, {"Citation": "Meyer-Ficca ML, Meyer RG, Jacobson EL, et al. Poly(ADP-ribose) polymerases: managing genome stability. Int J Biochem Cell Biol. 2005;37(5):920\u20136.", "ArticleIdList": ["15743666", "10.1016/j.biocel.2004.09.011"]}, {"Citation": "Csizmar CM, Saliba AN, Swisher EM, et al. PARP inhibitors and myeloid neoplasms: a double-edged sword. Cancers (Basel). 2021;13(24):6385.", "ArticleIdList": ["34945003", "10.3390/cancers13246385"]}, {"Citation": "Kontandreopoulou CN, Diamantopoulos PT, Tiblalexi D, et al. PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome. Blood Adv. 2021;5(22):4794\u2013805.", "ArticleIdList": ["34529761", "8759124", "10.1182/bloodadvances.2021004638"]}, {"Citation": "Gil-Kulik P, Dudzi\u0144ska E, Radzikowska-B\u00fcchner E, et al. Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells. BMC Cancer. 2020;20(1):435.", "ArticleIdList": ["32423430", "7236215", "10.1186/s12885-020-06903-4"]}, {"Citation": "Padella A, Ror\u00e0 Ghelli Luserna Di, A, Marconi G, et al. Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. J Hematol Oncol. 2022;15(1):10.", "ArticleIdList": ["35065680", "8783444", "10.1186/s13045-022-01228-0"]}, {"Citation": "Nemkov T, D\u2019Alessandro A, Reisz JA. Metabolic underpinnings of leukemia pathology and treatment. Cancer Rep (Hoboken). 2019;2(2): e1139.", "ArticleIdList": ["32721091", "10.1002/cnr2.1139"]}, {"Citation": "Gale RP. Can Immune therapy cure acute myeloid leukemia? Curr Treat Options Oncol. 2023;24(5):381\u20136.", "ArticleIdList": ["36949279", "10122615", "10.1007/s11864-023-01066-3"]}, {"Citation": "Maleknia M, Valizadeh A, Pezeshki SMS, Saki N. Immunomodulation in leukemia: cellular aspects of anti-leukemic properties. Clin Transl Oncol. 2020;22(1):1\u201310.", "ArticleIdList": ["31127471", "10.1007/s12094-019-02132-9"]}, {"Citation": "Karantanou C, Godavarthy PS, Krause DS. Targeting the bone marrow microenvironment in acute leukemia. Leuk Lymphoma. 2018;59(11):2535\u201345.", "ArticleIdList": ["29431560", "10.1080/10428194.2018.1434886"]}, {"Citation": "Pistritto G, Trisciuoglio D, Ceci C, et al. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY). 2016;8(4):603\u201319.", "ArticleIdList": ["27019364", "10.18632/aging.100934"]}, {"Citation": "Kaloni D, Diepstraten ST, Strasser A, et al. BCL-2 protein family: attractive targets for cancer therapy. Apoptosis. 2023;28(1\u20132):20\u201338.", "ArticleIdList": ["36342579", "10.1007/s10495-022-01780-7"]}, {"Citation": "Bah N, Maillet L, Ryan J, et al. Bcl-xL controls a switch between cell death modes during mitotic arrest. Cell Death Dis. 2014;5(6): e1291.", "ArticleIdList": ["24922075", "4611724", "10.1038/cddis.2014.251"]}, {"Citation": "Beyfuss K, Hood DA. A systematic review of p53 regulation of oxidative stress in skeletal muscle. Redox Rep. 2018;23(1):100\u201317.", "ArticleIdList": ["29298131", "6748683", "10.1080/13510002.2017.1416773"]}, {"Citation": "Teyssonneau D, Margot H, Cabart M, et al. Prostate cancer and PARP inhibitors: progress and challenges. J Hematol Oncol. 2021;14(1):51.", "ArticleIdList": ["33781305", "8008655", "10.1186/s13045-021-01061-x"]}, {"Citation": "Cortesi L, Rugo HS, Jackisch C. An overview of PARP inhibitors for the treatment of breast cancer. Target Oncol. 2021;16(3):255\u201382.", "ArticleIdList": ["33710534", "8105250", "10.1007/s11523-021-00796-4"]}, {"Citation": "Risdon EN, Chau CH, Price DK, et al. PARP inhibitors and prostate cancer: to infinity and beyond BRCA. Oncologist. 2021;26(1):e115\u201329.", "ArticleIdList": ["32790034", "10.1634/theoncologist.2020-0697"]}, {"Citation": "Slade D. Mitotic functions of poly(ADP-ribose) polymerases. Biochem Pharmacol. 2019;167:33\u201343.", "ArticleIdList": ["30910692", "7056360", "10.1016/j.bcp.2019.03.028"]}, {"Citation": "Engbrecht M, Mangerich A. The nucleolus and PARP1 in cancer biology. Cancers (Basel). 2020;12(7):1813.", "ArticleIdList": ["32640701", "10.3390/cancers12071813"]}, {"Citation": "Maluchenko NV, Feofanov AV, Studitsky VM. PARP-1-associated pathological processes: inhibition by natural polyphenols. Int J Mol Sci. 2021;22(21):11441.", "ArticleIdList": ["34768872", "8584120", "10.3390/ijms222111441"]}, {"Citation": "Dr\u00e9an A, Lord CJ, Ashworth A. PARP inhibitor combination therapy. Crit Rev Oncol Hematol. 2016;108:73\u201385.", "ArticleIdList": ["27931843", "10.1016/j.critrevonc.2016.10.010"]}, {"Citation": "Lin S, Zhang L, Zhang X, et al. Synthesis of novel dual target inhibitors of PARP and HSP90 and their antitumor activities. Bioorg Med Chem. 2020;28(9): 115434.", "ArticleIdList": ["32222339", "10.1016/j.bmc.2020.115434"]}, {"Citation": "Kim D, Nam HJ. PARP inhibitors: clinical limitations and recent attempts to overcome them. Int J Mol Sci. 2022;23(15):8412.", "ArticleIdList": ["35955544", "9369301", "10.3390/ijms23158412"]}, {"Citation": "Eskandari E, Eaves CJ. Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis. J Cell Biol. 2022. https://doi.org/10.1083/jcb.202201159 .", "ArticleIdList": ["10.1083/jcb.202201159", "35551578", "9106709"]}, {"Citation": "Saraei R, Marofi F, Naimi A, et al. Leukemia therapy by flavonoids: future and involved mechanisms. J Cell Physiol. 2019;234(6):8203\u201320.", "ArticleIdList": ["30500074", "10.1002/jcp.27628"]}]}], "History": [{"Year": "2023", "Month": "12", "Day": "11"}, {"Year": "2024", "Month": "2", "Day": "2"}, {"Year": "2024", "Month": "4", "Day": "12", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "4", "Day": "11", "Hour": "12", "Minute": "44"}, {"Year": "2024", "Month": "4", "Day": "11", "Hour": "11", "Minute": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["38602586", "10.1007/s12032-024-02324-6", "10.1007/s12032-024-02324-6"]}}]}